Track topics on Twitter Track topics that are important to you
Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, is pleased to welcome a new oncology advisor, Duke University’s John H. Sampson, M.D., Ph.D., to the Immunomic scientific advisory board as the company pursues application of the investigational LAMP-Vax platform technology in oncology. Dr. Sampson will advise on scientific and technical matters relating to brain […]
The post Immunomic Therapeutics adds John H. Sampson to scientific advisory board appeared first on CenterWatch News Online.
Original Article: Immunomic Therapeutics adds John H. Sampson to scientific advisory boardNEXT ARTICLE
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...